These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9032794

  • 1. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
    Ozaki H, Hayashi H, Oshima K.
    Ophthalmic Res; 1996; 28(6):356-60. PubMed ID: 9032794
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 3. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR, Chang SS, Park LS, Reppucci VS, Schiff WM, Schmidt AM.
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [Abstract] [Full Text] [Related]

  • 4. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Sep; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 5. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 6. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 7. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM.
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Cicik E, Tekin H, Akar S, Ekmekçi OB, Donma O, Koldaş L, Ozkan S.
    Ophthalmic Res; 2003 Nov; 35(5):251-5. PubMed ID: 12920337
    [Abstract] [Full Text] [Related]

  • 9. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H, Varinli I, Ozcan AA, Canataroglu A, Doran F, Varinli S.
    Ocul Immunol Inflamm; 2005 Nov; 13(5):375-81. PubMed ID: 16422002
    [Abstract] [Full Text] [Related]

  • 10. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 11. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC, De Rojas Silva MV, Rodríguez-García J, Rodríguez-Segade S, Sánchez-Salorio M.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [Abstract] [Full Text] [Related]

  • 12. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
    Umeda N, Ozaki H, Hayashi H, Kondo H, Uchida H, Oshima K.
    Ophthalmic Res; 2002 Dec; 34(1):43-7. PubMed ID: 11834884
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
    Sydorova M, Lee MS.
    Ophthalmic Res; 2005 Dec; 37(4):188-90. PubMed ID: 15990461
    [Abstract] [Full Text] [Related]

  • 14. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Deng J, Wu DZ, Gao R.
    Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
    [Abstract] [Full Text] [Related]

  • 15. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y, Gao S, Zhu Y, Shen X.
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [Abstract] [Full Text] [Related]

  • 16. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X, Ma K, Lu N, Hong T, Xu Y, Peng X.
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
    Kojima S, Yamada T, Tamai M.
    Jpn J Ophthalmol; 2001 Apr; 45(1):40-5. PubMed ID: 11163044
    [Abstract] [Full Text] [Related]

  • 18. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM, Nawaz MI, Ola MS, De Hertogh G, Opdenakker G, Geboes K.
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [Abstract] [Full Text] [Related]

  • 19. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M, Shoji J, Nakajima M, Kamura Y, Sato Y.
    Jpn J Ophthalmol; 2007 May; 51(2):100-4. PubMed ID: 17401618
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
    Yoshida S, Kobayashi Y, Nakama T, Zhou Y, Ishikawa K, Arita R, Nakao S, Miyazaki M, Sassa Y, Oshima Y, Izuhara K, Kono T, Ishibashi T.
    Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.